國立虎尾科技大學 |

Pharmacology and vitreoretinal surgery

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pharmacology and vitreoretinal surgery/ volume editor, Arnd Gandorfer.
other author:	Gandorfer, Arnd.
Published:	Basel :S. Karger, : 2009,
Description:	1 online resource :ill. (some col.) :
Notes:	A change of current concepts
Subject:	Retina - Surgery. -
Online resource:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111
ISBN:	9783805590303

Pharmacology and vitreoretinal surgery
Pharmacology and vitreoretinal surgery[electronic resource] /volume editor, Arnd Gandorfer. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Developments in ophthalmology,v. 441662-2790 ;. - Developments in ophthalmology ;v. 43..

A change of current concepts

Includes bibliographical references and indexes.

Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.

ISBN: 9783805590303Subjects--Topical Terms:

673947
Retina
--Surgery.

LC Class. No.: RE551 / .P43 2009

Dewey Class. No.: 617.7/3

National Library of Medicine Call No.: W1 / DE998NG v.44 2009

Pharmacology and vitreoretinal surgery
LDR:02105cam a2200265 a 4500 001 675775
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cn|||||||||
008 111107s2009 sz ob 001 0 eng d
020 $a 9783805590303
035 $a 248111
040 $a szbaska
050 1 0 $a RE551 $b .P43 2009
060 0 0 $a W1 $b DE998NG v.44 2009
060 1 0 $a WW 250 $b P536 2009
082 0 0 $a 617.7/3 $2 22
245 0 0 $a Pharmacology and vitreoretinal surgery $h [electronic resource] / $c volume editor, Arnd Gandorfer.
260 $a Basel : $b S. Karger, $c 2009
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Developments in ophthalmology, $x 1662-2790 ; $v v. 44
500 $a A change of current concepts
504 $a Includes bibliographical references and indexes.
520 $a Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.
650 0 $a Retina $x Surgery. $3 673947
650 0 $a Vitreous humor. $3 780625
650 0 $a Enzymes $x Therapeutic use. $3 780626
650 1 2 $a Vitreous Body $x surgery. $3 780627
650 2 2 $a Combined Modality Therapy. $3 780628
650 2 2 $a Retina $x surgery. $3 780629
650 2 2 $a Retinal Diseases $x surgery. $3 780630
650 2 2 $a Vitrectomy $x methods. $3 780631
650 2 2 $a Vitreous Body $x drug effects. $3 780632
700 1 $a Gandorfer, Arnd. $3 780624
830 0 $a Developments in ophthalmology ; $v v. 43. $3 780620
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111